Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Teekakirikul
Heterogeneous Myocyte Enhancer Factor-2 (Mef2) Activation in Myocytes Predicts Focal Scarring in Hypertrophic Cardiomyopathy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Myocyte Enhancer Factor 2 (MEF2)-Binding Site Is Required forGLUT4Gene Expression in Transgenic Mice
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Myocyte Enhancer Factor-2 (MEF2) in Diseases of Central Nervous System: A Mini Review
Exploratory Research and Hypothesis in Medicine
Role of Hippocampal Myocyte Enhancer Factor 2 (MEF2) in the Neuroplastic and Cognitive Effects of Environmental Stressors
Myocyte Enhancer Factor-Related B-Mef2 Is Developmentally Expressed in B Cells and Regulates the Immunoglobulin J Chain Promoter
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
High Expression of Myocyte Enhancer Factor 2C Predicts Poor Prognosis for Adult Acute Myeloid Leukaemia With Normal Karyotype
British Journal of Haematology
Hematology
High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy
PLoS ONE
Multidisciplinary
Hypertrophic Cardiomyopathy in Pregnancy
Journal of the Royal Society of Medicine
Medicine
Activation of the Myocyte Enhancer Factor-2 Transcription Factor by Calcium/Calmodulin-Dependent Protein Kinase-Stimulated Binding of 14-3-3 to Histone Deacetylase 5
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Recent Advances in Hypertrophic Cardiomyopathy
F1000Prime Reports
